Amanote Research
Register
Sign In
Bone Marrow IRF4 Level in Multiple Myeloma: An Indicator of Peripheral Blood Th17 and Disease
Oncotarget
- United States
doi 10.18632/oncotarget.19907
Full Text
Open PDF
Abstract
Available in
full text
Categories
Oncology
Date
August 3, 2017
Authors
Hua Bai
Shuang Wu
Rong Wang
Ji Xu
Lijuan Chen
Publisher
Impact Journals, LLC
Related search
Bone Marrow Angiogenesis in Multiple Myeloma
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Lysozyme in Bone Marrow and Peripheral Blood Cells
Journal of Histochemistry and Cytochemistry
Anatomy
Histology
Ficolled Bone Marrow Is Superior to Bone Marrow Buffy Coat for Detection of Minimal Residual Disease in Multiple Myeloma
Hematology
Hematology
Different Presentation of Multiple Myeloma in Bone Marrow Aspiration
Journal of Cancer Science and Clinical Therapeutics
Hematologic Disorders and Bone Marrow–Peripheral Blood Dynamics
Mathematical Modelling of Natural Phenomena
Modeling
Applied Mathematics
Simulation
Effect of Thalidomide Therapy on Bone Marrow Angiogenesis in Multiple Myeloma
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
The Functional Significance of the Bone Marrow Microenvironment in Multiple Myeloma Development and Progression
OA Immunology
Identification of Malignant Plasma Cell Precursors in the Bone Marrow of Multiple Myeloma.
Journal of Clinical Investigation
Medicine
Monitoring of Minimal Residual Disease in Adult Acute Myeloid Leukemia Using Peripheral Blood as an Alternative Source to Bone Marrow
Haematologica
Hematology
